Messung der Kosten von Krebserkrankungen in Deutschland

Abubakar I, Tillmann T, Banerjee A (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X‑S, Bannon F, Ahn JV, Johnson CJ, Bonaventure A (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (Concord-2). Lancet 385:977–1010

American Cancer Society (2021) Cancer facts and figures 2021

Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229

Brazier J, Ratcliffe J, Saloman J, Tsuchiya A (2017) Measuring and valuing health benefits for economic evaluation. Oxford University Press, Oxford

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E (2014) Cancer survival in Europe 1999–2007 by country and age: results of Eurocare-5—a population-based study. Lancet Oncol 15:23–34

Dietsche S (2018) Risk-factors for poverty following cancer. Oncol Res Treat 41(Suppl 4):21

ENCR (2014) Prostate (PRC) cancer factsheet. European Network of Cancer Registries, Ispra

Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C (2015) The global burden of cancer 2013. JAMA Oncol 1:505–527

Global Health Data Exchange (2021) GBD results tool

Gold MR, Stevenson D, Fryback DG (2002) Halys and Qalys and Dalys, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health 23:115–134

Haagsma JA, De Noordhout CM, Polinder S, Vos T, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar ME, Speybroeck N, Salomon JA (2015) Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metrics 13:10

Hernandez D, Schlander M (2021) Income loss after a cancer diagnosis in Germany: an analysis based on the socio-economic panel survey. Cancer Med 10(11):3726–3740

Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N (2019) Budget impact analysis of cancer screening: a methodological review. Appl Health Econ Health Policy 17:493–511

Mehlis K, Witte J, Surmann B, Kudlich M, Apostolidis L, Walther J, Jäger D, Greiner W, Winkler EC (2020) The patient-level effect of the cost of cancer care–financial burden in German cancer patients. BMC Cancer 20(1):529

OECD (2021) Expenditure by disease, age and gender under the System of Health Accounts (SHA) Framework Organisation for Economic Co-operation and Development (OECD)

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

RKI (2021) ZfKD database query. https://www.krebsdaten.de/Krebs/EN/Database/databasequery_step1_node.html. Zugegriffen: 01.09.2021

Salomon JA, Haagsma JA, Davis A, De Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N (2015) Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 3:e712–e723

Statistisches Bundesamt (2021) Pressemitteilung Nr. N 010 vom 3. Februar 2021

Tarricone R (2006) Cost-of-illness analysis: what room in health economics? Health Policy 77:51–63

WHO (2004) The global burden of disease: 2004 update. World Health Organization, Geneva